Mr Buck is a bio-physicist who has spent his career in a variety of entrepreneurial and management positions in industrial companies. Oliver has served as founder and Managing Director of several companies in the fields of manufacturing, technology, demilitarisation, pharmaceuticals and information technologies. Oliver is the co-founder of ITM Isotopen Technologien Munchen AG, one of the largest isotope manufacturing and distribution companies in the world, founded with Technical University of Munich. Since 2012, Oliver has acted as senior advisor to the CEO in a role that continues to support the ITM group as it has become a leader in next generation medical isotopes and theranostics. Oliver is an alumnus of the German National Academy for Security Policy and the 'Young Leaders Program' of the Atlantik Brucke/American Council on Germany. He is also the member of Risk Management Committee.
Oliver Buck
Follow
Get notifications in MyBN when activity occurs.
Oliver Buck
Lists and Charts
Total Shareholder Return as at 01/12/25
| Rank | Company | 1 Yr | 5 Yr |
|---|---|---|---|
| 1448th | Gratifii | -38.24% | -34.33% |
| 1449th | Altech Batteries | -38.3% | -5.91% |
| 1450th | Telix Pharmaceuticals | -38.48% | 33.57% |
| 1451st | Infinity Metals | -38.71% | -32.93% |
| 1452nd | HITIQ | -39.03% | 0% |
1675 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
27/04/22
$1.09m Bought
Telix Pharmaceuticals
Total value as at the date of the transaction
Powered by Morningstar ®
Person Activity
|
NEW ROLE: Non-Executive Director, Telix Pharmaceuticals | 03 Nov 2020 |
Related Information
Positions - Previous
| Position | Company | Year | Company's current rank |
|---|---|---|---|
Non-Executive Director
|
2017 - 2022 |
Directors Interest
| Company | Date | Transaction type | Number of shares | Price per share | Transaction value | Nature of change |
|---|---|---|---|---|---|---|
| 2022-04-27 | Bought | 250,000 | $4.37 | $1,092,500 | On-market trade |
Powered by Morningstar ®
X